Pancreatic Cell News Volume 14.36 | Sep 19 2023

    0
    12








    2023-09-18 | PACN 14.36


    Pancreatic Cell News by STEMCELL Technologies
    Vol. 14.36 – 19 September, 2023
    TOP STORY

    A Microprotein N1DARP Encoded by LINC00261 Promotes Notch1 Intracellular Domain (N1ICD) Degradation via Disrupting USP10-N1ICD Interaction to Inhibit Chemoresistance in Notch1-Hyperactivated Pancreatic Cancer

    Researchers identified a previously uncharacterized microprotein, Notch1 degradation-associated regulatory polypeptide (N1DARP), encoded by LINC00261. N1DARP knockout accelerated tumor progression and enhanced stem cell properties in pancreatic cancer organoids.
    [Cell Discovery]

    Full Article
    An ISSCR 2022 COREdinates Webinar: Differentiation of High-Quality hPSCs Using STEMdiff â„¢ and TeSR â„¢-AOF, presented by Kim Snyder. Click to Watch Now.
    PUBLICATIONSRanked by the impact factor of the journal

    Noncanonical CDK4 Signaling Rescues Diabetes in a Mouse Model by Promoting β Cell Differentiation

    The authors tested whether replacement of endogenous CDK4 with the inhibitor-resistant mutant CDK4-R24C rescued the loss of β cell mass in IRS2-deficient mice.
    [Journal Of Clinical Investigation]

    Full ArticleGraphical Abstract

    Hydroxychloroquine in Stage 1 Type 1 Diabetes

    To test whether blocking innate immaune cells modulated progression of the disease, scientists randomly assigned 273 individuals with stage 1 Type 1 diabetes (T1D) to treatment with hydroxychloroquine or placebo and assessed whether hydroxychloroquine treatment delayed or prevented progression to stage 2.
    [Diabetes Care]

    Abstract

    TFEB and TFE3 Control Glucose Homeostasis by Regulating Insulin Gene Expression

    Transcription factor EB (TFEB) overexpression was sufficient to inhibit insulin transcription, whereas beta cells depleted of both TFEB and TFE3 failed to suppress insulin gene expression in response to amino acid deprivation.
    [EMBO Journal]

    Full ArticleGraphical Abstract

    Genome-Wide Differential Expression Profiling of Long Non-Coding RNAs in FOXA2 Knockout iPSC-Derived Pancreatic Cells

    The authors employed their recently established FOXA2-deficient iPSCs (FOXA2−/− iPSCs) to investigate changes in lncRNA profiles and their correlation with dysregulated mRNAs during the pancreatic progenitor and pancreatic islet stages.
    [Cell Communication And Signaling]

    Full Article

    Self-Adaptive Nanoregulator to Mitigate Dynamic Immune Evasion of Pancreatic Cancer

    Investigators engineered a novel peptide-drug conjugate-based self-adaptive nanoregulator for mitigating dynamic immune evasion of PDAC.
    [Advanced Materials]

    Abstract

    DNA-Methylation Signature Accurately Differentiates Pancreatic Cancer from Chronic Pancreatitis in Tissue and Plasma

    Genome-wide variations of DNA-methylation, messenger RNA and microRNA level as well as combinations thereof were analyzed in 345 tissue samples for marker identification. To improve diagnostic performance, researchers established a random-forest machine-learning approach.
    [Gut]

    AbstractFull Article

    Enhanced Antitumor Immunity following Neoadjuvant Chemoradiotherapy Mediates a Favourable Prognosis in Women with Resected Pancreatic Cancer

    Scientists investigated sex disparities in clinical outcomes and tumor immune profiles in patients with PDAC who underwent upfront resection or resection preceded by gemcitabine-based neoadjuvant chemoradiotherapy.
    [Gut]

    AbstractFull Article

    KMT2A Associates with PHF5A-PHF14-HMG20A-RAI1 Subcomplex in Pancreatic Cancer Stem Cells and Epigenetically Regulates Their Characteristics

    Targeting the protein subcomplex in pancreatic cancer stem cells with a KMT2A-WDR5 inhibitor attenuated their self-renewal capacity, cell viability, and in vivo tumorigenicity.
    [Nature Communications]

    Full Article
    Explore this validated protocol for high-efficiency gene editing of Human Pluripotent Stem Cells using the ArciTectâ„¢ CRISPR-Cas9 System.
    REVIEWS

    Quantifying Beta Cell Function in the Preclinical Stages of Type 1 Diabetes

    Scientists describe the metabolic changes that occur in the early pre-symptomatic stages of type 1 diabetes with respect to both insulin secretion and insulin sensitivity, as well as the measurable outcomes that can be derived from the available tests.
    [Diabetologia]

    Full ArticleGraphical Abstract

    Biological Characteristics of Pancreatic Ductal Adenocarcinoma: Initiation to Malignancy, Intracellular to Extracellular

    The authors elucidate the alterations in intracellular molecules and the extracellular environment that occur during the progression of PDAC.
    [Cancer Letters]

    Full Article
    INDUSTRY AND POLICY NEWS

    Mounjaro Approved by NICE For Treating Type 2 Diabetes

    The National Institute for Health and Care Excellence (NICE) have published draft guidance approving the use of tirzepatide (brand name Mounjaro) for treating type 2 diabetes in England and Wales.
    [Diabetes UK]

    Editorial
    FEATURED EVENT

    New Vista of Tissue Engineering & Regenerative Medicine

    October 16 – 19, 2023
    Hong Kong

    > See All Events

    JOB OPPORTUNITIES

    Faculty Position – Endocrinology, Diabetes & Metabolism

    Beth Israel Deaconess Medical Center & Harvard Medical School – Boston, Massachusetts, United States

    Laboratory Assistant – Pancreatic Cancer Research

    University of California, Los Angeles – Los Angeles, California, United States

    Assistant Professor – Cancer, Cardiovascular and Metabolic Health, or Brain, Mind, and Behavior

    Northwestern University – Chicago, Illinois, United States

    Lab Assistant – Liver and Pancreatic Transplant

    University of California – Los Angeles, California, United States

    Post Doctoral Fellow – Autoimmunity and Transplantation

    University of Missouri – Columbia, Missouri, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Pancreatic Cell News Twitter